Cite
HARVARD Citation
Sharpton, S. et al. (2022). Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis. Alimentary pharmacology & therapeutics. 56 (10), pp. 1475-1485. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sharpton, S. et al. (2022). Gut metagenome‐derived signature predicts hepatic decompensation and mortality in NAFLD‐related cirrhosis. Alimentary pharmacology & therapeutics. 56 (10), pp. 1475-1485. [Online].